Altor Bioscience Corporation
Records under this name other than the patents Altor Bioscience Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 54 patents it holds.
Back to Altor Bioscience Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,229,668 | Maximizing T-Cell Memory and Compositions and Methods Therefor Formerly held In force · High confidence | In force | High confidence | |
| US 8,772,451 | Soluble TCR Molecules and Methods of Use Term ended Term ended Nov 10, 2024 · High confidence | Term ended | Term ended Nov 10, 2024 | High confidence |
| US 9,290,560 | Soluble TCR Molecules and Methods of Use Term ended Term ended Nov 10, 2024 · High confidence | Term ended | Term ended Nov 10, 2024 | High confidence |
| US 7,456,263 | P53 binding T cell receptor molecules Term ended Term ended Sep 25, 2023 · From the USPTO record | Term ended | Term ended Sep 25, 2023 | From the USPTO record |
| US 8,105,830 | Polyspecific binding molecules and uses thereof Term ended Term ended Aug 15, 2021 · From the USPTO record | Term ended | Term ended Aug 15, 2021 | From the USPTO record |
| US 6,534,633 | Polyspecific binding molecules and uses thereof Term ended Term ended Oct 21, 2019 · From the USPTO record | Term ended | Term ended Oct 21, 2019 | From the USPTO record |
| US 7,074,905 | Soluble MHC complexes and methods of use thereof Lapsed on the fee record Ended Jul 11, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 11, 2018 | From the USPTO record |
| US 6,232,445 | Soluble MHC complexes and methods of use thereof Term ended Term ended Oct 29, 2017 · From the USPTO record | Term ended | Term ended Oct 29, 2017 | From the USPTO record |
| US 7,511,122 | Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria Formerly held Lapsed on the fee record Ended Mar 31, 2017 · From the USPTO record | Lapsed on the fee record | Ended Mar 31, 2017 | From the USPTO record |
| US 7,074,904 | MHC complexes and uses thereof Term ended Term ended Jan 12, 2016 · From the USPTO record | Term ended | Term ended Jan 12, 2016 | From the USPTO record |